RxDoctor Payments Data

Jan Diamond

Family Medicine · Richmond, CANPI 1326116898

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $117,425 of the $148,263 with a category attached, or 79.2%. 4 manufacturers reported payments, led by Gilead at 50.7% of the total. Reporting peaked in 2023 at $40,552 and has fallen 63.1% since, to $14,964 in 2025. Among family medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$148,263in general payments, 2019–2025

Across 248 payments — averaging $597.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$75K
  • AbbVie$73K
  • Novo Nordisk$32
  • GSK$27

What the payments were for

  • Consulting fees$5,5804%
  • Speaking & faculty fees$117,42579%
  • Travel & lodging$18,35412%
  • Food & beverage$6,9045%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Gilead125$75,210
AbbVie121$72,994
Novo Nordisk1$32
GSK1$27

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$148,263 in reported general payments places this provider in the 95th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California →

Other family medicine in Richmond

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →